BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 23525412)

  • 1. Extent of mitochondrial hexokinase II dissociation during ischemia correlates with mitochondrial cytochrome c release, reactive oxygen species production, and infarct size on reperfusion.
    Pasdois P; Parker JE; Halestrap AP
    J Am Heart Assoc; 2012 Dec; 2(1):e005645. PubMed ID: 23525412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hexokinase II dissociation alone cannot account for changes in heart mitochondrial function, morphology and sensitivity to permeability transition pore opening following ischemia.
    Pereira GC; Lee L; Rawlings N; Ouwendijk J; Parker JE; Andrienko TN; Henley JM; Halestrap AP
    PLoS One; 2020; 15(6):e0234653. PubMed ID: 32579577
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of hexokinase in cardioprotection - mechanism and potential for translation.
    Halestrap AP; Pereira GC; Pasdois P
    Br J Pharmacol; 2015 Apr; 172(8):2085-100. PubMed ID: 25204670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temperature preconditioning of isolated rat hearts--a potent cardioprotective mechanism involving a reduction in oxidative stress and inhibition of the mitochondrial permeability transition pore.
    Khaliulin I; Clarke SJ; Lin H; Parker J; Suleiman MS; Halestrap AP
    J Physiol; 2007 Jun; 581(Pt 3):1147-61. PubMed ID: 17395631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-Time Fluorescence Measurements of ROS and [Ca2+] in Ischemic / Reperfused Rat Hearts: Detectable Increases Occur only after Mitochondrial Pore Opening and Are Attenuated by Ischemic Preconditioning.
    Andrienko T; Pasdois P; Rossbach A; Halestrap AP
    PLoS One; 2016; 11(12):e0167300. PubMed ID: 27907091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aldose reductase mediates myocardial ischemia-reperfusion injury in part by opening mitochondrial permeability transition pore.
    Ananthakrishnan R; Kaneko M; Hwang YC; Quadri N; Gomez T; Li Q; Caspersen C; Ramasamy R
    Am J Physiol Heart Circ Physiol; 2009 Feb; 296(2):H333-41. PubMed ID: 19060123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticle-Mediated Delivery of Mitochondrial Division Inhibitor 1 to the Myocardium Protects the Heart From Ischemia-Reperfusion Injury Through Inhibition of Mitochondria Outer Membrane Permeabilization: A New Therapeutic Modality for Acute Myocardial Infarction.
    Ishikita A; Matoba T; Ikeda G; Koga J; Mao Y; Nakano K; Takeuchi O; Sadoshima J; Egashira K
    J Am Heart Assoc; 2016 Jul; 5(7):. PubMed ID: 27451459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preconditioning or Postconditioning with 8-Br-cAMP-AM Protects the Heart against Regional Ischemia and Reperfusion: A Role for Mitochondrial Permeability Transition.
    Khaliulin I; Ascione R; Maslov LN; Amal H; Suleiman MS
    Cells; 2021 May; 10(5):. PubMed ID: 34067674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo hyperoxic preconditioning protects against rat-heart ischemia/reperfusion injury by inhibiting mitochondrial permeability transition pore opening and cytochrome c release.
    Petrosillo G; Di Venosa N; Moro N; Colantuono G; Paradies V; Tiravanti E; Federici A; Ruggiero FM; Paradies G
    Free Radic Biol Med; 2011 Feb; 50(3):477-83. PubMed ID: 21130864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
    Petrosillo G; Colantuono G; Moro N; Ruggiero FM; Tiravanti E; Di Venosa N; Fiore T; Paradies G
    Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1487-93. PubMed ID: 19684190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore.
    Liu CW; Yang F; Cheng SZ; Liu Y; Wan LH; Cong HL
    Cardiovasc Ther; 2017 Feb; 35(1):3-9. PubMed ID: 27580017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of mitochondrial permeability transition pore opening by ischemic preconditioning is probably mediated by reduction of oxidative stress rather than mitochondrial protein phosphorylation.
    Clarke SJ; Khaliulin I; Das M; Parker JE; Heesom KJ; Halestrap AP
    Circ Res; 2008 May; 102(9):1082-90. PubMed ID: 18356542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of succinate and ROS in reperfusion injury - A critical appraisal.
    Andrienko TN; Pasdois P; Pereira GC; Ovens MJ; Halestrap AP
    J Mol Cell Cardiol; 2017 Sep; 110():1-14. PubMed ID: 28689004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral benzodiazepine receptor-induced myocardial protection is mediated by inhibition of mitochondrial membrane permeabilization.
    Obame FN; Zini R; Souktani R; Berdeaux A; Morin D
    J Pharmacol Exp Ther; 2007 Oct; 323(1):336-45. PubMed ID: 17640950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Melatonin Receptor Agonist Ramelteon Induces Cardioprotection that Requires MT2 Receptor Activation and Release of Reactive Oxygen Species.
    Stroethoff M; Goetze L; Torregroza C; Bunte S; Raupach A; Heinen A; Mathes A; Hollmann MW; Huhn R
    Cardiovasc Drugs Ther; 2020 Jun; 34(3):303-310. PubMed ID: 32236860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reducing mitochondrial bound hexokinase II mediates transition from non-injurious into injurious ischemia/reperfusion of the intact heart.
    Nederlof R; Gürel-Gurevin E; Eerbeek O; Xie C; Deijs GS; Konkel M; Hu J; Weber NC; Schumacher CA; Baartscheer A; Mik EG; Hollmann MW; Akar FG; Zuurbier CJ
    J Physiol Biochem; 2016 Aug; 73(3):323-333. PubMed ID: 28258543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoflurane preconditioning protects against ischemia-reperfusion injury partly by attenuating cytochrome c release from subsarcolemmal mitochondria in isolated rat hearts.
    Qian LP; Zhu SS; Cao JL; Zeng YM
    Acta Pharmacol Sin; 2005 Jul; 26(7):813-20. PubMed ID: 15960887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondria "THE" target of myocardial conditioning.
    Boengler K; Lochnit G; Schulz R
    Am J Physiol Heart Circ Physiol; 2018 Nov; 315(5):H1215-H1231. PubMed ID: 30004243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nutritional preconditioning induced by astragaloside Ⅳ on isolated hearts and cardiomyocytes against myocardial ischemia injury via improving Bcl-2-mediated mitochondrial function.
    Luo Y; Wan Q; Xu M; Zhou Q; Chen X; Yin D; He H; He M
    Chem Biol Interact; 2019 Aug; 309():108723. PubMed ID: 31228469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening.
    Bhamra GS; Hausenloy DJ; Davidson SM; Carr RD; Paiva M; Wynne AM; Mocanu MM; Yellon DM
    Basic Res Cardiol; 2008 May; 103(3):274-84. PubMed ID: 18080084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.